HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 293 filers reported holding HAEMONETICS CORP in Q2 2018. The put-call ratio across all filers is 13.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $288,384 | -84.0% | 3,485 | -86.3% | 0.02% | -82.2% |
| Q3 2021 | $1,801,000 | -6.2% | 25,517 | -11.5% | 0.10% | -1.9% |
| Q2 2021 | $1,921,000 | +17.3% | 28,833 | +95.6% | 0.10% | +10.8% |
| Q1 2021 | $1,637,000 | +10.7% | 14,743 | +18.4% | 0.09% | -13.1% |
| Q4 2020 | $1,479,000 | -44.4% | 12,453 | -59.2% | 0.11% | +24.4% |
| Q3 2020 | $2,660,000 | +6.5% | 30,486 | +9.3% | 0.09% | +34.4% |
| Q2 2020 | $2,498,000 | -19.8% | 27,889 | -10.8% | 0.06% | -22.0% |
| Q1 2020 | $3,115,000 | +26.9% | 31,256 | +46.3% | 0.08% | +141.2% |
| Q4 2019 | $2,455,000 | -36.6% | 21,364 | -30.4% | 0.03% | -26.1% |
| Q3 2019 | $3,875,000 | +5.5% | 30,716 | +0.6% | 0.05% | -35.2% |
| Q2 2019 | $3,673,000 | +500.2% | 30,523 | +264.6% | 0.07% | +317.6% |
| Q1 2018 | $612,000 | -90.2% | 8,371 | -92.2% | 0.02% | -90.6% |
| Q4 2017 | $6,257,000 | – | 107,724 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bridge City Capital, LLC | 40,541 | $5,114,000 | 2.20% |
| Lisanti Capital Growth, LLC | 53,385 | $6,734,000 | 2.20% |
| Nitorum Capital, L.P. | 279,510 | $35,257,000 | 2.05% |
| CROWN ADVISORS MANAGEMENT, INC. | 20,000 | $2,523,000 | 1.69% |
| Millrace Asset Group, Inc. | 11,400 | $1,438,000 | 1.69% |
| COOKSON PEIRCE & CO INC | 145,884 | $18,402,000 | 1.61% |
| Endurant Capital Management LP | 32,594 | $4,111,000 | 1.48% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 111,000 | $14,002,000 | 1.38% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 110,065 | $13,884,000 | 1.37% |
| EMERALD ADVISERS, LLC | 203,640 | $25,687,000 | 1.20% |